| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |